MyFinsight
Home
Blog
About
Contact
Download
Download image
Net loss
-$10,206,517
Total other expense,
net
-$7,238,705
Loss from operations
-$2,967,812
Forgiveness of unrelated
vendor payables
$2,142,297
Interest income
$76,589
Change in the fair value
of warrant...
-$54,312
Fair value of common
stock to be issued for...
$7,360,000
Total operating
expenses
$2,967,812
Loss on exchange of
common stock for...
-$1,740,000
Interest expense,
related parties
$215,903
Change in fair value of
deferred underwriting...
-$196,000
General and
administrative
$2,967,812
Back
Back
Income Statement
source: myfinsight.com
Liminatus Pharma, Inc. (LIMNW)
Liminatus Pharma, Inc. (LIMNW)